Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia

Internal Medicine

Volumn 49, Issue 15, 2010, Pages 1581-1585

  Watanabe, Minemori ^a   Asai, Chikako ^a   Ishikawa, Kota ^a   Kiyota, Atsushi ^a   Terada, Tatsuhiro ^b   Kono, Satoshi ^b   Miyajima, Hiroaki ^b   Okumura, Ataru ^a  

^a Okazaki City Hospital   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aceruloplasminemia; Central diabetes insipidus; Hypothalamic hypothyroidism

Indexed keywords

ARGIPRESSIN; C PEPTIDE; CERULOPLASMIN; DESMOPRESSIN ACETATE; GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; LEVOTHYROXINE SODIUM; PIOGLITAZONE; SODIUM CHLORIDE; VOGLIBOSE;

ACERULOPLASMINEMIA; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CAUDATE NUCLEUS; COMPUTER ASSISTED TOMOGRAPHY; COPPER BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DENTATE NUCLEUS; DIABETES INSIPIDUS; ENDOCRINE FUNCTION TEST; FATIGUE; FERRITIN BLOOD LEVEL; GLYCEMIC CONTROL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMIC HYPOTHYROIDISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TOLERANCE TEST; IRON OVERLOAD; LIOTHYRONINE BLOOD LEVEL; LIVER BIOPSY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA OSMOLALITY; POLYDIPSIA; POLYURIA; PUTAMEN; SEQUENCE ANALYSIS; SODIUM BLOOD LEVEL; THALAMUS; THYROTROPIN BLOOD LEVEL; URINE OSMOLALITY; URINE VOLUME;

ADULT; CERULOPLASMIN; DIABETES INSIPIDUS, NEUROGENIC; HUMANS; HYPOTHALAMIC DISEASES; HYPOTHYROIDISM; IRON METABOLISM DISORDERS; MALE; NEURODEGENERATIVE DISEASES;

EID: 77956211619     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3508     Document Type: Article

References (24)

1. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37: 761-767, 1987.
2. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 16: 205-213, 2003.
3. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 241: 2746-2751, 1966.
4. Klomp LWJ, Gitlin JD. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum Mol Genet 5: 1989-1996, 1996.
5. Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RTA, Gitlin JD. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92: 2539-2543, 1995.
6. Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res 39: 15-23, 2006.
7. McNeill A, Pandolfo M, Kuhn J, Shang H, Miyajima H. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 60: 200-205, 2008.
8. Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med 42: 599-604, 2003.
9. Muroi R, Yagyu H, Kobayashi H, et al. Early onset insulindependent diabetes mellitus as an initial manifestation of aceruloplasminaemia. Diabet Med 23: 1136-1139, 2006.
10. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 5: 81-84, 1996.
11. Nakane S, Shirabe S, Suenaga A, Yoshimura T, Nakamura T. A case of hereditary ceruloplasmin deficiency with hemosiderosis. Rinsho Shinkeigaku (Clin Neurol) 39: 347-351, 1999 (in Japanese, Abstract in English).
12. Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol 13: 4755-4760, 2007.
13. Brissot P, Troadec MB, Bardou-Jacquet E, et al. Current approach to hemochromatosis. Blood Rev 22: 195-210, 2008.
14. Miyajima H, Kohno S, Takahashi Y, Yonekawa O, Kanno T. Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 53: 617-619, 1999.
15. Bisset GW, Chowdrey HS. Control of release of vasopressin by endocrine reflexes. Q J Exp Physiol 73: 811-872, 1988.
16. Bourque CW, Oliet SHR. Osmoreceptors in the central nervous system. Annu Rev Physiol 59: 601-619, 1997.
17. Hershman JM, Pittmann JA Jr. Control of thyrotropin secretion in man. N Eng J Med 285: 997-1006, 1971.
18. Jeong SY, David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278: 27144-27148, 2003.
19. Gonzalez-Cuyar LF, Perry G, Miyajima H, et al. Redox active iron accumulation in aceruloplasminemia. Neuropathology 28: 466-471, 2008.
20. Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a Japanese family. Ann Neurol 37: 646-656, 1995.
21. Faglia G, Beck-Peccoz P, Ferrari C, et al. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab 37: 595- 601, 1973.
22. Mitsuma T, Shenkman L, Suphavai A, Hollander CS. Hypothalamic hypothyroidism: diminished thyroidal response to thyrotropin-releasing hormone. Am J Med Sci 265: 315-319, 1973.
23. Faglia G, Beck-Peccoz P, Ballabio M, Nava C. Excess of F- subunit of thyrotropin (TSH) in patients with idiopathic central hypothyroidism due to the secretion of TSH with reduced biological activity. J Clin Endocrinol Metab 56: 908-914, 1983.
24. Kaneko K, Yoshida K, Arima K, et al. Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia. J Neuropathol Exp Neurol 61: 1069-1077, 2002.